{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T03:16:03Z","timestamp":1773890163798,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["K08EY034930"],"award-info":[{"award-number":["K08EY034930"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ajoc.2025.102490","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T17:51:15Z","timestamp":1764957075000},"page":"102490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Extraocular muscle volume reduction in a patient treated with two courses of teprotumumab for thyroid eye disease"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-6728-4398","authenticated-orcid":false,"given":"Hanna","family":"Richkind","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6297-4674","authenticated-orcid":false,"given":"Marissa K.","family":"Shoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5551-1156","authenticated-orcid":false,"given":"Megan","family":"Routzong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Granet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Don O.","family":"Kikkawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3022-4649","authenticated-orcid":false,"given":"Jolene C.","family":"Rudell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajoc.2025.102490_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/cxo.12472","article-title":"Thyroid eye disease: a review","volume":"100","author":"Weiler","year":"2017","journal-title":"Clin Exp Optom"},{"issue":"1","key":"10.1016\/j.ajoc.2025.102490_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imj.15067","article-title":"Medical and surgical treatment of thyroid eye disease","volume":"52","author":"Hall","year":"2022","journal-title":"Intern Med J"},{"issue":"2","key":"10.1016\/j.ajoc.2025.102490_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1136\/bjophthalmol-2020-317806","article-title":"Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease","volume":"106","author":"Jain","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2025.102490_bib4","first-page":"3037","article-title":"Side effects and adverse events after treatment with teprotumumab for thyroid eye disease: a retrospective observational case series","volume":"65","author":"Hashemi","year":"2024","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102490_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/WNO.0000000000001134","article-title":"Teprotumumab in clinical practice: recommendations and considerations from the OPTIC trial investigators","volume":"41","author":"Douglas","year":"2021","journal-title":"J Neuro Ophthalmol"},{"key":"10.1016\/j.ajoc.2025.102490_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mri.2012.05.001","article-title":"3D slicer as an image computing platform for the quantitative imaging network","author":"Fedorov","year":"2012","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102490_bib7","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/01676830.2021.1933081","article-title":"Teprotumumab for chronic thyroid eye disease","volume":"41","author":"Ozzello","year":"2022","journal-title":"Orbit"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102490_bib8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ophtha.2021.10.017","article-title":"Teprotumumab efficacy, safety, and durability in longer-duration thyroid eye disease and Re-treatment: OPTIC-X study","volume":"129","author":"Douglas","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2025.102490_bib9","article-title":"The rate of retreatment in patients treated with teprotumumab: a multicenter Study of 119 Patients with 1 year follow up","author":"Ugradar","year":"2024","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102490_bib10","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/IOP.0000000000002072","article-title":"Echographic assessment of extraocular muscle response to teprotumumab","volume":"38","author":"Tran","year":"2022","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"4","key":"10.1016\/j.ajoc.2025.102490_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1080\/01676830.2022.2122515","article-title":"Differential effects of teprotumumab treatment based on fat-to-muscle ratio in patients with thyroid eye disease","volume":"42","author":"Ting","year":"2023","journal-title":"Orbit"},{"issue":"5","key":"10.1016\/j.ajoc.2025.102490_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/IOP.0000000000002337","article-title":"Reduction in extraocular muscle cross-sectional area and correlation with extraocular motility and diplopia following teprotumumab for thyroid eye disease","volume":"39","author":"Reshef","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"3","key":"10.1016\/j.ajoc.2025.102490_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/WNO.0b013e31814a5ef8","article-title":"Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease","volume":"27","author":"Zoumalan","year":"2007","journal-title":"J Neuro Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625002439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993625002439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:52:07Z","timestamp":1773877927000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993625002439"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":13,"alternative-id":["S2451993625002439"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102490","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extraocular muscle volume reduction in a patient treated with two courses of teprotumumab for thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2025.102490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102490"}}